Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
OPTIONAL LOGO HERE Morbidity associated with total abdominal hysterectomy as treatment for endometrial cancer: outcomes from 2years data collection OPTIONAL LOGO HERE Dr Faiza Waliullah, Dr Alexandra Rice, Dr Kate Christen, Dr Oliver Milling Smith, Department of Obstetrics and Gynaecology, Forth Valley Royal Hospital, Larbert,UK Objectives Methods Results A retrospective audit of the morbidities associated with total abdominal hysterectomy in patients with endometrial cancer diagnosed and treated within Forth Valley Health Board between January 2009 and December 2010. 76 patients were diagnosed with endometrial cancer, having been identified by the Gynaecology Oncology team and had a total abdominal hysterectomy as part of their management plan. Of these, 41 patients were included in the study as they were both diagnosed and treated in Forth Valley. • The average patient was 66 years of age (range 35- 87) and had an average hospital stay of 5 days. • The average haemoglobin prior to total hysterectomy was 13.0g/dl and day 2 post op 11.1g/dl, which equated to an average drop of 2.3g/dl. Estimated blood loss ranged from minimal to 3500ml, average loss being 464ml. • 95% of patients received intra-operative antibiotics. • The 2 patients with no documentation of intraoperative antibiotics did not develop any post-op infections. • 10 patients developed post-op infections. • All of them received antibiotics and a source was identified in 40%. 98% had LMWH prescribed and 56% had documentation of TED stockings. • There were no reported DVTs. • Endometrial cancer is the fourth most common cause of cancer in women in the UK1,2. • Total abdominal hysterectomy (TAH) has been widely used as the treatment of choice for endometrial cancer. • It is however invasive surgery with an associated morbidity. • Total laparoscopic hysterectomy (TLH) is a minimally invasive technique and studies have shown it to be safe and effective. (ref NICE) A retrospective study was undertaken, reviewing various outcomes to measure morbidity. These included pre and day 2 post operative haemoglobin, any return to theatre, post op infection, duration and strength of analgesia and length of stay in hospital. Patient age and past medical history were also noted. Conclusions Of those patients who met the inclusion criteria (n=41), 1. 100% stayed in hospital for >2 days compared to 52% of the patients who underwent a laparoscopic hysterectomy in a large RCT. 2. Post operative complications reported in the study for open hysterectomies were at 21%. 3. Post operative infection rates were 24%, most of which were pyrexia of unknown origin and all were treated with antibiotics. 4. No patients developed thromboembolism and prophylaxis with LMWH was given to 98% of the patients. However, there were 2 patients who had a prolonged hospital stay. 6. One who developed post operative urinary infection, small bowel obstruction which spontaneously resolved and wound infection and the other patient with excessive bleeding requiring blood transfusion. 7. A further study was undertaken comparing TLH to TAH, results of which are shown in the graphs. References 1. ISD Online, Cancer Incidence, Mortality and Survival data. 2008, Information and Statistics Division, NHS Scotland. 2.Office for National Statistics, Cancer Statistics registrations: Registrations of cancer diagnosed in 2005, England. Series MB1 no.36. 2008, National Statistics: London. 3.Sokol AI, Green IC. Laparoscopic Hysterectomy. Clin Obstet Gynecol. Sep;52(3):304-12. 2009